Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5RAX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,673
Award facts
- Contract value 100% obligated
- $14,672.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 22, 2026, the Defense Logistics Agency awarded a delivery order valued at $14,672.91 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL). The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is Conshohocken, Pennsylvania, with an ultimate completion date of January 23, 2026. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at up to $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor providing critical medical supplies to federal agencies, particularly the Department of Defense and military healthcare systems. The company's federal contracting portfolio encompasses a diverse range of pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices. Through its prime IDC with DLA Troop Support Medical, AmerisourceBergen demonstrates the capability to efficiently fulfill government requirements for essential pharmaceutical commodities required by military treatment facilities and other federal medical institutions worldwide.
Quick answers
Who was awarded contract SPE2DR26F5RAX?
SPE2DR26F5RAX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F5RAX worth?
The government has obligated $14,673 on SPE2DR26F5RAX.
Is contract SPE2DR26F5RAX an order under another contract?
Yes. SPE2DR26F5RAX is a delivery order under SPE2DR25D2013, an indefinite delivery contract.
Was contract SPE2DR26F5RAX competed?
The extent of competition for SPE2DR26F5RAX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award